TEVA's CEO resigned last month due to claims of bribery with several countries. US Dept of Justice is currently investigating.
Also, they've lost 4 patent rights over the last few months, one being to their product Copaxone which solely brings in about 1/3 of their revenue.
(1)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
-
-
-
-
-
-
-